Diabetic Kidney Disease: Clinical Trials

143 trials for Diabetic Kidney Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 21 unknown, 19 recruiting, 13 not yet recruiting. 37 Phase 2, 30 Not applicable, 16 Phase 3, 14 Phase 4, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 237Completed 19, Terminated 6, Recruiting 4, Unknown 4, Active not recruiting 2, Withdrawn 2
Not applicable30Completed 13, Unknown 7, Not yet recruiting 4, Recruiting 3, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 316Completed 6, Terminated 4, Unknown 4, Withdrawn 2
Phase 414Completed 8, Not yet recruiting 3, Active not recruiting 1, Recruiting 1, Unknown 1
Phase 110Completed 4, Recruiting 3, Terminated 3
Early Phase 12Unknown 2

Follow Diabetic Kidney Disease: new trials by email Literature Review of Diabetic Kidney Disease trials Research Report on Diabetic Kidney Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes
clinical and laboratory CKM staging evaluation - Type 2 Diabetes Mellitus, Cardiovascular-Kidney-Metabolic Syndrome
Not yet recruitingAssiut University2312026-10-202026-10-02
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Finerenone 10 MG, Empagliflozin 10 MG - Diabetic Kidney Disease
Phase 4Not yet recruitingWashington D.C. Veterans Affairs Medical Center302026-10-012026-08-21
Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney Disease
Diabetic Kidney Disease, Diabetic Nephropathies
Not yet recruitingAssiut University1202026-09-012026-08-19
Evaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
Intervention Name Clinical decision support system for diabetic kidney disease (DKD-CDSS), Routine guideline-based diabetes management - Type 2 Diabetes Mellitus, Diabetic Kidney Disease
Not applicableNot yet recruitingFirst Affiliated Hospital of Chongqing Medical University30002026-07-302026-07-16
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
Finerenone - Type 2 Diabetes Mellitus, Diabetic Kidney Disease
Not yet recruitingFirst Affiliated Hospital of Chongqing Medical University4252026-07-302026-07-21
Effect of Chinese Herbal Medicine on Renal Function in Diabetic Kidney Disease
Chinese herbal formula DKD-1 - Diabetic Kidney Disease
Not applicableNot yet recruitingChina Medical University Hospital662026-06-112026-06-18
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
MTX-439, Placebo - Healthy Adult Participants, Diabetic Kidney Disease
Phase 1RecruitingMediar Therapeutics882026-05-192026-06-29
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Finerenone, Spironolactone (drug) - Heart Failure, Diabetic Kidney Disease
Phase 4Not yet recruitingHospital de Messejana Dr. Carlos Alberto Studart Gomes602026-04-012026-05-13
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
Usual care for diabetic kidney disease management without primary care provider., Pharmacist-led validated diabetic kidney disease decision support algorithm. - Diabetic Kidney Disease, Type 2 Diabetes
Not applicableRecruitingNova Scotia Health Authority1202026-03-012026-03-18
Gut Microbiota and Serum Metabolites as Predictors of Glycemic Variability and Outcomes in Diabetic Kidney Disease
Diabetic Kidney Disease
Not yet recruitingEighth Affiliated Hospital, Sun Yat-sen University2702026-02-012026-01-20
Immune System in Diabetic Kidney Disease
Diabetes, Diabetic Kidney Disease
Enrolling by invitationUniversity Medical Centre Ljubljana902025-12-012026-02-23
Formoterol in Diabetes
Formoterol furmarate (20 μg) - Diabetic Nephropathies, Diabetic Kidney Disease
Phase 2RecruitingMedical University of South Carolina1202025-12-012026-02-05
Oxygen Therapy in Diabetic Kidney Disease
Oxygen Therapy - Diabetic Kidney Disease
Not applicableNot yet recruitingAssiut University802025-08-012025-05-06
P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease
2HPβCD - Diabetic Kidney Disease
Phase 2WithdrawnZyVersa Therapeutics, Inc.2025-06-112025-11-25
Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients
Sugar cane polysaccharide, Control - Diabetic Kidney Disease
Not applicableNot yet recruitingShanghai Changzheng Hospital602025-04-012025-04-02
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
AP303 150μg, Placebo 150μg - Diabetic Kidney Disease
Phase 1RecruitingAlebund Pharmaceuticals182025-02-272025-09-11
Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease
Hypoxia administration study group, Renal clairance study - Diabetes, Diabetic Kidney Disease
Not applicableRecruitingPoitiers University Hospital302025-02-132025-04-09
"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"
Standard Peritoneal Dialysis, Incremental Peritonal Dialysis - Chronic Kidney Disease, Diabetic Kidney Disease
Not applicableActive not recruitingInstituto Mexicano del Seguro Social1002024-11-012026-01-13
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients
Diabetic Kidney Disease
Not yet recruitingPower Life Sciences Inc.5002024-11-012023-10-26
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.
R3R01, Placebo - Diabetic Kidney Disease
Phase 2RecruitingRiver 3 Renal Corp.602024-10-102026-09-23

Showing 20 of 143. Sign in to see all of them.

Narrower conditions

Diabetic Nephropathies (143)  ·  Diabetes Mellitus, Type 2 (38)  ·  Diabetes Mellitus (27)  ·  Renal Insufficiency, Chronic (23)  ·  Diabetes Mellitus, Type 1 (13)  ·  Kidney Diseases (9)  ·  Albuminuria (8)  ·  Diabetes Complications (6)  ·  Obesity (5)  ·  Hypertension (4)  ·  Proteinuria (4)  ·  Cardiovascular Diseases (3)  ·  Pediatric Obesity (3)  ·  Diabetic Retinopathy (2)  ·  Disease (2)

Broader conditions

Endocrine System Diseases (143)  ·  Female Urogenital Diseases (143)  ·  Female Urogenital Diseases and Pregnancy Complications (143)  ·  Male Urogenital Diseases (143)  ·  Urogenital Diseases (143)  ·  Urologic Diseases (143)  ·  Diabetes Complications (137)  ·  Kidney Diseases (134)  ·  Diabetes Mellitus (116)  ·  Nutritional and Metabolic Diseases (69)  ·  Glucose Metabolism Disorders (66)  ·  Metabolic Diseases (66)  ·  Pathological Conditions, Signs and Symptoms (44)  ·  Pathologic Processes (27)  ·  Disease Attributes (24)

Interventions

p-Aminohippuric Acid (7)  ·  Iohexol (6)  ·  empagliflozin (5)  ·  finerenone (5)  ·  dapagliflozin (3)  ·  semaglutide (3)  ·  Angiotensin-Converting Enzyme Inhibitors (2)  ·  Canagliflozin (2)  ·  Cholecalciferol (2)  ·  Dextrans (2)  ·  Irbesartan (2)  ·  Liraglutide (2)  ·  Losartan (2)  ·  Magnetic Resonance Imaging (2)  ·  Pentoxifylline (2)

Sponsors

University of Colorado, Denver (10)  ·  Assiut University (7)  ·  Amsterdam UMC, location VUmc (4)  ·  Renalytix AI, Inc. (4)  ·  Bayer (3)  ·  Chinese PLA General Hospital (3)  ·  Duke University (3)  ·  Gilead Sciences (3)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3)  ·  Prokidney (3)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (3)  ·  Steno Diabetes Center Copenhagen (3)  ·  Eli Lilly and Company (2)  ·  First Affiliated Hospital of Chongqing Medical University (2)  ·  Medical University of South Carolina (2)

Countries

United States (57)  ·  China (24)  ·  Denmark (10)  ·  Canada (9)  ·  Australia (8)  ·  France (7)  ·  Hong Kong (6)  ·  Italy (6)  ·  Netherlands (6)  ·  South Korea (6)  ·  Egypt (5)  ·  Israel (5)  ·  Japan (5)  ·  Mexico (5)  ·  Sweden (5)

Top investigators

Petter Bjornstad, MD (4)  ·  Helen C Looker (2)  ·  Pringgodigdo Nugroho, MD (2)  ·  Aida Lydia, MD, PhD (1)  ·  Alex R Chang, MD, MS (1)  ·  Anna Solini, MD, PhD (1)  ·  Ari Cisneros, Bachelor (1)  ·  Ashraf Anwar Thabet, Professor (1)  ·  Ayub Akbari, MD (1)  ·  Carel le Roux, MBBS PhD (1)

Results publications

PMID 38682786, PMID 38770818, PMID 39171639, PMID 39963952, PMID 41805697, PMID 14704836, PMID 14768849, PMID 15780110, PMID 16952978, PMID 17035611, PMID 19584489, PMID 20727043, PMID 22245613, PMID 22638939, PMID 22737281, PMID 22777106, PMID 23929927, PMID 24391410, PMID 26180085, PMID 27430216, PMID 27753201, PMID 28449402, PMID 29649631, PMID 30964439, PMID 31018581, PMID 31194487, PMID 31506292, PMID 31659655, PMID 31665733, PMID 31864393, PMID 32600374, PMID 32685766, PMID 33184642, PMID 33280027, PMID 33358451, PMID 33436470, PMID 34400461, PMID 34449181, PMID 34775784, PMID 34879977, PMID 34886001, PMID 35072046, PMID 35333363, PMID 35369650, PMID 35613364, PMID 35679002, PMID 35846333, PMID 36251465, PMID 36287567, PMID 36328655

NIH funding

2014 (2), 2015 (2), 1KL2RR025015-01 (1), 2016 (1), 2017 (1), 2018 (1), K23HL159292 (1), P30DK017047 (1), R21AT002367 (1), R34DK102166 (1), T32DK063687 (1), UL1TR002535 (1)